Angola - Hospital beds

Hospital beds (per 1,000 people) in Angola was reported at 0.8 in 2005, according to the World Bank collection of development indicators, compiled from officially recognized sources.



angola hospital beds per 1 000 people wb data




We will not not share your email with third parties and you can unsubscribe at any time.
Please Paste this Code in your Website
width
height
 Preview


Hospital beds include inpatient beds available in public, private, general, and specialized hospitals and rehabilitation centers. In most cases beds for both acute and chronic care are included.


Angola | Health

Ratio of school attendance of orphans to school attendance of non-orphans ages 10-14
0.85
Total alcohol consumption per capita (liters of pure alcohol, projected estimates, 15+ years of age)
7.6
Prevalence of anemia among women of reproductive age (% of women ages 15-49)
44.8 %
Prevalence of anemia among children (% of children under 5)
52.1 %
Prevalence of anemia among non-pregnant women (% of women ages 15-49)
44.5 %
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions (% of total)
61.8 %
Number of infant deaths
104291
Cause of death, by injury (% of total)
10.7 %
Number of under-five deaths
169310
Cause of death, by non-communicable diseases (% of total)
27.4 %
Number of neonatal deaths
53164
Adults (ages 15+) living with HIV
290000 Persons
AIDS estimated deaths (UNAIDS estimates)
12000
Female adults with HIV (% of population ages 15+ with HIV)
59.71 %
Prevalence of HIV, total (% of population ages 15-49)
2.2 %
Mortality rate, under-5 (per 1,000)
157
Mortality rate, under-5, female (per 1,000 live births)
149
Mortality rate, under-5, male (per 1,000 live births)
165
Under-5 mortality rate (per 1,000 live births): Q1 (lowest)
288
Under-5 mortality rate (per 1,000 live births): Q2
261
Under-5 mortality rate (per 1,000 live births): Q3
260
Under-5 mortality rate (per 1,000 live births): Q4
230
Under-5 mortality rate (per 1,000 live births): Q5 (highest)
205
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70
25 %
Mortality rate; neonatal (per 1;000 live births)
48.7
Median birth interval (months): Q1 (lowest)
27
Median birth interval (months): Q2
27
Median birth interval (months): Q3
25
Median birth interval (months): Q4
27
Median birth interval (months): Q5 (highest)
27
Access to an improved water source, rural (% of rural population): Q1 (lowest)
11 %
Access to an improved water source, rural (% of rural population): Q2
14 %
Access to an improved water source, rural (% of rural population): Q3
26 %
Access to an improved water source, rural (% of rural population): Q4
39 %
Access to an improved water source , rural (% of rural population): Q5 (highest)
58 %
Access to an improved water source, urban (% of urban population): Q1 (lowest)
66 %
Access to an improved water source, urban (% of urban population): Q2
62 %
Access to an improved water source, urban (% of urban population): Q3
66 %
Access to an improved water source, urban (% of urban population): Q4
71 %
Access to an improved water source, urban (% of urban population): Q5 (highest)
82 %
Children (0-14) living with HIV
25000 Persons
Prevalence of HIV, female (% ages 15-24)
0.9 %
Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)
25.3
Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)
32.1
Prevalence of HIV, male (% ages 15-24)
0.5 %
Antiretroviral therapy coverage (% of people with advanced HIV infection)
29 %
AIDS deaths in adults and children (high estimate)
16000
AIDS deaths in adults and children (low estimate)
7700
AIDS deaths in adults and children
11000
Adults (ages 15+) newly infected with HIV
22000
Children (ages 0-14) newly infected with HIV
4300
Adults (ages 15+) and children (ages 0-14) newly infected with HIV
26000
Incidence of HIV (% of uninfected population ages 15-49)
0.19 %
Children orphaned by HIV/AIDS
130000
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
40 %
Adults (ages 15+) and children (0-14 years) living with HIV
320000 Persons
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q1 (lowest)
20.4 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q2
18.3 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q3
28.4 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q4
28.1 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q5 (highest)
34.7 %
Immunization, Hib3 (% of children ages 12-23 months)
64 %
Immunization, BCG (% of one-year-old children)
79 %
Vaccinations (BCG) (% of children ages 12-23 months): Q1 (lowest)
53.9 %
Vaccinations (BCG) (% of children ages 12-23 months): Q2
56.7 %
Vaccinations (BCG) (% of children ages 12-23 months): Q3
73.4 %
Vaccinations (BCG) (% of children ages 12-23 months): Q4
70.1 %
Vaccinations (BCG) (% of children ages 12-23 months): Q5 (highest)
83.6 %
Immunization, DPT (% of children ages 12-23 months)
64 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q1 (lowest)
23.1 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q2
23.4 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q3
34.4 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q4
36.4 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q5 (highest)
47.3 %
Immunization, measles (% of children ages 12-23 months)
55 %
Vaccinations (Measles) (% of children ages 12-23 months): Q1 (lowest)
37.8 %
Vaccinations (Measles) (% of children ages 12-23 months): Q2
43.7 %
Vaccinations (Measles) (% of children ages 12-23 months): Q3
56.2 %
Vaccinations (Measles) (% of children ages 12-23 months): Q4
55.2 %
Vaccinations (Measles) (% of children ages 12-23 months): Q5 (highest)
68.2 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q1 (lowest)
14.9 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q2
17.9 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q3
13.7 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q4
10.5 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q5 (highest)
8.3 %
Immunization, Pol3 (% of one-year-old children)
70 %
Hospital beds
0.8
Nurses and midwives
1.66
Physicians
0.166
Deaths among children under five years of age due to malaria
8.3 %
Reported malaria deaths (total)
6909
Notified cases of malaria (per 100;000 people)
21593
Incidence of malaria (per 1,000 population at risk)
124
Mosquito net use by children (any mosquito net) (% of children under 5): Q1 (lowest)
19.9 %
Mosquito net use by children (any mosquito net) (% of children under 5): Q2
17.9 %
Mosquito net use by children (any mosquito net) (% of children under 5): Q3
25.3 %
Mosquito net use by children (any mosquito net) (% of children under 5): Q4
19.5 %
Mosquito net use by children (any mosquito net) (% of children under 5): Q5 (highest)
20.6 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q1 (lowest)
29.4 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q2
25.8 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q3
39.6 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q4
33.5 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q5 (highest)
37.6 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q1 (lowest)
26.5 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q2
24.3 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q3
27.4 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q4
19.3 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q5 (highest)
22.7 %
Mosquito net use by children (insecticide-treated net) (% of children under 5): Q2
16.3 %
Mosquito net use by children (insecticide-treated net) (% of children under 5): Q3
22 %
Mosquito net use by children (insecticide-treated net) (% of children under 5): Q4
17.1 %
Use of insecticide-treated bed nets (% of under-5 population)
25.9 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q1 (lowest)
25.5 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q2
22.1 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q3
32.6 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q4
28.6 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q5 (highest)
30.6 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q1 (lowest)
23 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q2
24.3 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q3
26.9 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q4
14.4 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q5 (highest)
14.7 %
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q1 (lowest)
29.1 %
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q2
54.7 %
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q3
75 %
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q4
78.9 %
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q5 (highest)
79.2 %
Use of Intermittent Preventive Treatment of malaria, 2+ doses of SP/Fansidar (% of pregnant women)
17.5 %
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q1 (lowest)
0 %
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q2
4.1 %
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q3
3 %
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q4
3.5 %
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q5 (highest)
5.6 %
Treatment of fever (% of children under 5 with fever): Q1 (lowest)
18.2 %
Treatment of fever (% of children under 5 with fever): Q2
32.6 %
Treatment of fever (% of children under 5 with fever): Q3
28.2 %
Treatment of fever (% of children under 5 with fever): Q4
35.8 %
Treatment of fever (% of children under 5 with fever): Q5 (highest)
51.8 %
Children with fever receiving antimalarial drugs (% of children under age 5 with fever)
28.3 %
Number of maternal mortality deaths
5400
Lifetime risk of maternal death (1 in: rate varies by country)
32
Lifetime risk of maternal death
3.08 %
Prevalence of anemia among pregnant women
47.1 %
Risk of catastrophic expenditure for surgical care (% of people at risk)
51.4 %
Risk of impoverishing expenditure for surgical care (% of people at risk)
55.5 %
Improved sanitation facilities (% of population with access)
51.6 %
Access to improved sanitation facilities, rural (% of rural population): Q1 (lowest)
3 %
Access to improved sanitation facilities, rural (% of rural population): Q2
3 %
Access to improved sanitation facilities, rural (% of rural population): Q3
7 %
Access to improved sanitation facilities, rural (% of rural population): Q4
15 %
Access to improved sanitation facilities, rural (% of rural population): Q5 (highest)
40 %
Improved sanitation facilities, urban (% of urban population with access)
88.6 %
Access to improved sanitation facilities, urban (% of urban population): Q1 (lowest)
58 %
Access to improved sanitation facilities, urban (% of urban population): Q2
82 %
Access to improved sanitation facilities, urban (% of urban population): Q3
90 %
Access to improved sanitation facilities, urban (% of urban population): Q4
96 %
Pregnant women receiving prenatal care of at least four visits (% of pregnant women)
31.5 %
Antenatal care (any skilled personnel) (% of women with a birth): Q1 (lowest)
63.3 %
Antenatal care (any skilled personnel) (% of women with a birth): Q2
84 %
Antenatal care (any skilled personnel) (% of women with a birth): Q3
96.1 %
Antenatal care (any skilled personnel) (% of women with a birth): Q4
98.9 %
Antenatal care (any skilled personnel) (% of women with a birth): Q5 (highest)
98.8 %
Pregnant women receiving prenatal care
79.8 %
Antenatal care (doctor) (% of women with a birth): Q1 (lowest)
5.5 %
Antenatal care (doctor) (% of women with a birth): Q2
7.3 %
Antenatal care (doctor) (% of women with a birth): Q3
9 %
Antenatal care (doctor) (% of women with a birth): Q4
19.1 %
Antenatal care (doctor) (% of women with a birth): Q5 (highest)
23.2 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q1 (lowest)
48.6 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q2
54.5 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q3
58.8 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q4
55.9 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q5 (highest)
73.6 %
ARI treatment (% of children under 5 taken to a health provider)
58 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q1 (lowest)
7.7 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q2
8.7 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q3
8.3 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q4
7.8 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q5 (highest)
6.1 %
Exclusive breastfeeding (% of children under 6 months)
11 %
Assistance during delivery (any skilled personnel) (% of births): Q1 (lowest)
16.4 %
Assistance during delivery (any skilled personnel) (% of births): Q2
34.7 %
Assistance during delivery (any skilled personnel) (% of births): Q3
61.2 %
Assistance during delivery (any skilled personnel) (% of births): Q4
86.1 %
Assistance during delivery (any skilled personnel) (% of births): Q5 (highest)
94.1 %
Births attended by skilled health staff (% of total)
49.9 %
Place of delivery (births at health facility) (% of births): Q1 (lowest)
14.3 %
Place of delivery (births at health facility) (% of births): Q2
27.7 %
Place of delivery (births at health facility) (% of births): Q3
59.9 %
Place of delivery (births at health facility) (% of births): Q4
82.9 %
Place of delivery (births at health facility) (% of births): Q5 (highest)
94.1 %
Assistance during delivery (doctor) (% of births): Q1 (lowest)
0.6 %
Assistance during delivery (doctor) (% of births): Q2
1.5 %
Assistance during delivery (doctor) (% of births): Q3
5.8 %
Assistance during delivery (doctor) (% of births): Q4
10.3 %
Assistance during delivery (doctor) (% of births): Q5 (highest)
21.5 %
Low-birthweight babies (% of births)
12 %
Diabetes prevalence (% of population ages 20 to 79)
4.1 %
Prevalence of diarrhea (% of children under 5): Q1 (lowest)
20.2 %
Prevalence of diarrhea (% of children under 5): Q2
20.4 %
Prevalence of diarrhea (% of children under 5): Q3
24.9 %
Prevalence of diarrhea (% of children under 5): Q4
27.5 %
Prevalence of diarrhea (% of children under 5): Q5 (highest)
22.6 %
Prevalence of children with fever (% of children under 5): Q1 (lowest)
28.1 %
Prevalence of children with fever (% of children under 5): Q2
27.2 %
Prevalence of children with fever (% of children under 5): Q3
26.3 %
Prevalence of children with fever (% of children under 5): Q4
28.4 %
Prevalence of children with fever (% of children under 5): Q5 (highest)
21.6 %
Prevalence of underweight, weight for age, female (% of children under 5)
14.6 %
Prevalence of underweight, weight for age, male (% of children under 5)
16.6 %
Malnutrition prevalence, weight for age (% of children under 5)
15.6 %
Malaria cases reported
2769305
Maternal mortality ratio (modeled estimate, per 100,000 live births)
477
People practicing open defecation, rural (% of rural population): Q1 (lowest)
83 %
People practicing open defecation, rural (% of rural population): Q2
78 %
People practicing open defecation, rural (% of rural population): Q3
57 %
People practicing open defecation, rural (% of rural population): Q4
48 %
People practicing open defecation, rural (% of rural population): Q5 (highest)
31 %
People practicing open defecation, rural (% of rural population)
53.8 %
People practicing open defecation, urban (% of urban population): Q1 (lowest)
15 %
People practicing open defecation, urban (% of urban population): Q2
0 %
People practicing open defecation, urban (% of urban population): Q3
0 %
People practicing open defecation, urban (% of urban population): Q4
0 %
People practicing open defecation, urban (% of urban population): Q5 (highest)
0 %
People practicing open defecation, urban (% of urban population)
0.5 %
People practicing open defecation (% of population)
30.3 %
Diarrhea treatment (% of children under 5 receiving oral rehydration and continued feeding)
31.7 %
Diarrhea treatment (% of children under 5 who received ORS packet)
34.9 %
Prevalence of overweight, female (% of female adults)
34.6 %
Prevalence of overweight, male (% of male adults)
18.6 %
Prevalence of overweight, weight for height, female (% of children under 5)
5.5 %
Prevalence of overweight, weight for height, male (% of children under 5)
5.1 %
Prevalence of overweight (% of children under 5)
5.3 %
Prevalence of stunting, height for age, female (% of children under 5)
26.1 %
Prevalence of stunting, height for age, male (% of children under 5)
32.4 %
Malnutrition prevalence, height for age (% of children under 5)
29.2 %
Suicide mortality rate (per 100,000 population)
20.5
Mortality caused by road traffic injury (per 100,000 people)
24.4
Prevalence of wasting, weight for height, female (% of children under 5)
8.1 %
Prevalence of wasting, weight for height, male (% of children under 5)
8.2 %
Prevalence of wasting (% of children under 5)
8.2 %
Prevalence of severe wasting, weight for height, female (% of children under 5)
4.2 %
Prevalence of severe wasting, weight for height, male (% of children under 5)
4.3 %
Prevalence of severe wasting, weight for height (% of children under 5)
4.3 %
Tuberculosis treatment success rate (% of registered cases)
34 %
Tuberculosis case detection rate (all forms)
64 %
Incidence of tuberculosis (per 100,000 people)
370
Tuberculosis death rate (per 100,000 people)
45
Deaths due to tuberculosis among HIV-negative people, high uncertainty bound (per 100,000 population)
66
Deaths due to tuberculosis among HIV-negative people, low uncertainty bound (per 100,000 population)
17
Newborns protected against tetanus
78 %
External resources for health (% of total expenditure on health)
2.63 %
Out-of-pocket health expenditure (% of total expenditure on health)
23.96 %
Out-of-pocket health expenditure (% of private expenditure on health)
67.04 %
Health expenditure per capita
179 USD
Health expenditure per capita, PPP (constant 2005 international $)
239
Health expenditure, private (% of GDP)
1.18 %
Health expenditure, public (% of total health expenditure)
64.26 %
Health expenditure, public (% of government expenditure)
5 %
Health expenditure, public (% of GDP)
2.12 %
Health expenditure, total (% of GDP)
3.31 %
Refugee population by country or territory of asylum
15555
Refugee population by country or territory of origin
11869
Number of people who are undernourished
3200000
Prevalence of undernourishment (% of population)
14.2 %
Depth of the food deficit (kilocalories per person per day)
90
Depth of hunger (kilocalories per person per day)
320
Consumption of iodized salt (% of households)
44.7 %
Vitamin A supplements for postpartum women (% of women with a birth): Q1 (lowest)
18.7 %
Vitamin A supplements for postpartum women (% of women with a birth): Q2
23.4 %
Vitamin A supplements for postpartum women (% of women with a birth): Q3
30.9 %
Vitamin A supplements for postpartum women (% of women with a birth): Q4
27.5 %
Vitamin A supplements for postpartum women (% of women with a birth): Q5 (highest)
26.1 %
Vitamin A supplements for children (% of children ages 6-59 months): Q1 (lowest)
26 %
Vitamin A supplements for children (% of children ages 6-59 months): Q2
28.6 %
Vitamin A supplements for children (% of children ages 6-59 months): Q3
32.9 %
Vitamin A supplements for children (% of children ages 6-59 months): Q4
29.1 %
Vitamin A supplements for children (% of children ages 6-59 months): Q5 (highest)
36 %
Vitamin A supplementation coverage rate (% of children ages 6-59 months)
6 %
Adolescent fertility rate (births per 1,000 women ages 15-19)
162
Mortality rate, adult, female (per 1,000 female adults)
317
Mortality rate, adult, male (per 1,000 male adults)
365
Birth rate, crude
45
Death rate, crude
13.42
Mean number of children ever born to women aged 40-49: Q1 (lowest)
7
Mean number of children ever born to women aged 40-49: Q2
7.3
Mean number of children ever born to women aged 40-49: Q3
6.9
Mean number of children ever born to women aged 40-49: Q4
6.4
Mean number of children ever born to women aged 40-49: Q5 (highest)
5.5
Current use of contraception (modern method) (% of married women): Q1 (lowest)
1.2 %
Current use of contraception (modern method) (% of married women): Q2
1.5 %
Current use of contraception (modern method) (% of married women): Q3
1 %
Current use of contraception (modern method) (% of married women): Q4
3.4 %
Current use of contraception (modern method) (% of married women): Q5 (highest)
13.5 %
Contraceptive prevalence, modern methods (% of women ages 15-49)
4.8 %
Current use of contraception (any method) (% of married women): Q1 (lowest)
2.2 %
Current use of contraception (any method) (% of married women): Q2
2.2 %
Current use of contraception (any method) (% of married women): Q3
2.6 %
Current use of contraception (any method) (% of married women): Q4
5.1 %
Current use of contraception (any method) (% of married women): Q5 (highest)
16.8 %
Contraceptive prevalence (% of women ages 15-49)
17.7 %
Mortality rate, infant, female (per 1,000 live births)
87.9
Mortality rate, infant (per 1,000 live births)
96
Mortality rate, infant, male (per 1,000 live births)
104
Infant mortality rate (per 1,000 live births): Q1 (lowest)
167
Infant mortality rate (per 1,000 live births): Q2
155
Infant mortality rate (per 1,000 live births): Q3
155
Infant mortality rate (per 1,000 live births): Q4
141
Infant mortality rate (per 1,000 live births): Q5 (highest)
129
Life expectancy at birth, female (years)
54.22 years
Life expectancy at birth, total (years)
52.67 years
Life expectancy at birth, male (years)
51.19 years
Fertility rate, total (births per woman)
6
Total fertility rate (TFR) (births per woman): Q1 (lowest)
8
Total fertility rate (TFR) (births per woman): Q2
7.4
Total fertility rate (TFR) (births per woman): Q3
6.7
Total fertility rate (TFR) (births per woman): Q4
4.9
Total fertility rate (TFR) (births per woman): Q5 (highest)
2.8
Survival to age 65, female (% of cohort)
50.24 %
Survival to age 65, male (% of cohort)
44.46 %
Female headed households (% of households with a female head)
21.7 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q1 (lowest)
46.6 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q2
44.6 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q3
39.2 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q4
21.2 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q5 (highest)
7.2 %
Teenage mothers (% of women ages 15-19 who have had children or are currently pregnant)
42.5 %
Female population 00-04
2402000 Persons
Population ages 0-4, female (% of female population)
18.6 %
Male population 00-04
2433000 Persons
Population ages 0-4, male (% of male population)
19.11 %
Female population 05-09
2022000 Persons
Population ages 5-9, female (% of female population)
15.56 %
Male population 05-09
2035000 Persons
Population ages 5-9, male (% of male population)
15.9 %
Female population 10-14
1689000 Persons
Population ages 10-14, female (% of female population)
12.94 %
Male population 10-14
1696000 Persons
Population ages 10-14, male (% of male population)
13.2 %
Female population 15-19
1392000 Persons
Population ages 15-19, female (% of female population)
10.66 %
Male population 15-19
1390000 Persons
Population ages 15-19, male (% of male population)
10.8 %
Female population 20-24
1142000 Persons
Population ages 20-24, female (% of female population)
8.76 %
Male population 20-24
1125000 Persons
Population ages 20-24, male (% of male population)
8.74 %
Female population 25-29
942000 Persons
Population ages 25-29, female (% of female population)
7.24 %
Male population 25-29
918000 Persons
Population ages 25-29, male (% of male population)
7.16 %
Female population 30-34
770000 Persons
Population ages 30-34, female (% of female population)
5.91 %
Male population 30-34
753000 Persons
Population ages 30-34, male (% of male population)
5.88 %
Female population 35-39
626000 Persons
Population ages 35-39, female (% of female population)
4.79 %
Male population 35-39
614000 Persons
Population ages 35-39, male (% of male population)
4.78 %
Female population 40-44
496000 Persons
Population ages 40-44, female (% of female population)
3.79 %
Male population 40-44
484000 Persons
Population ages 40-44, male (% of male population)
3.75 %
Female population 45-49
395000 Persons
Population ages 45-49, female (% of female population)
3.04 %
Male population 45-49
380000 Persons
Population ages 45-49, male (% of male population)
2.96 %
Female population 50-54
324000 Persons
Population ages 50-54, female (% of female population)
2.5 %
Male population 50-54
302000 Persons
Population ages 50-54, male (% of male population)
2.36 %
Female population 55-59
265000 Persons
Population ages 55-59, female (% of female population)
2.05 %
Male population 55-59
238000 Persons
Population ages 55-59, male (% of male population)
1.86 %
Female population 60-64
211000 Persons
Population ages 50-64, female (% of female population)
1.62 %
Male population 60-64
183000 Persons
Population ages 50-64, male (% of male population)
1.42 %
Female population 65-69
140000 Persons
Population ages 65-69, female (% of female population)
1.05 %
Male population 65-69
119000 Persons
Population ages 65-69, male (% of male population)
0.9099 %
Population ages 65 and above (% of total)
2.31 %
Female population 70-74
94000 Persons
Population ages 70-74, female (% of female population)
0.737 %
Male population 70-74
77000 Persons
Population ages 70-74, male (% of male population)
0.6112 %
Female population 75-79
58000 Persons
Population ages 75-79, female (% of female population)
0.4447 %
Male population 75-79
45000 Persons
Population ages 75-79, male (% of male population)
0.349 %
Population ages 80 and above, female
42000 Persons
Population ages 80 and above, female (% of female population)
0.3067 %
Male population 80+
29000 Persons
Population ages 80 and above, male (% of male population)
0.2112 %
Age population, age 06, female, interpolated
406144 Persons
Age population, age 06, male, interpolated
408923 Persons
Age population, age 07, female, interpolated
391779 Persons
Age population, age 07, male, interpolated
394199 Persons
Age population, age 08, female, interpolated
377848 Persons
Age population, age 08, male, interpolated
379995 Persons
Age population, age 09, female, interpolated
364328 Persons
Age population, age 09, male, interpolated
366264 Persons
Age population, age 10, female, interpolated
351235 Persons
Age population, age 10, male
353019 Persons
Age population, age 11, female, interpolated
338583 Persons
Age population, age 11, male
340268 Persons
Age population, age 12, female, interpolated
326170 Persons
Age population, age 12, male
327687 Persons
Age population, age 13, female, interpolated
313904 Persons
Age population, age 13, male
315116 Persons
Age population, age 14, female, interpolated
301870 Persons
Age population, age 14, male
302680 Persons
Age population, age 15, female, interpolated
290244 Persons
Age population, age 15, male, interpolated
290683 Persons
Age population, age 16, female, interpolated
278984 Persons
Age population, age 16, male, interpolated
279094 Persons
Age population, age 17, female, interpolated
268166 Persons
Age population, age 17, male, interpolated
267800 Persons
Age population, age 18, female, interpolated
257841 Persons
Age population, age 18, male, interpolated
256792 Persons
Age population, age 19, female, interpolated
247967 Persons
Age population, age 19, male, interpolated
246113 Persons
Age population, age 20, female, interpolated
238413 Persons
Age population, age 20, male, interpolated
235800 Persons
Age population, age 21, female, interpolated
229164 Persons
Age population, age 21, male, interpolated
225803 Persons
Age population, age 22, female, interpolated
220382 Persons
Age population, age 22, male, interpolated
216419 Persons
Age population, age 23, female, interpolated
212122 Persons
Age population, age 23, male, interpolated
207781 Persons
Age population, age 24, female, interpolated
204288 Persons
Age population, age 24, male, interpolated
199746 Persons
Age population, age 25, female, interpolated
196737 Persons
Age population, age 25, male, interpolated
192007 Persons
Age dependency ratio (% of working-age population)
99.86 %
Age dependency ratio, old (% of working-age population)
4.62 %
Age dependency ratio, young (% of working-age population)
95.23 %
Population, female (% of total)
50.38 %
Completeness of birth registration, rural
25.8 %
Completeness of birth registration, urban
39.9 %
Completeness of birth registration
35.6 %